We think the surprisingly high tariff rate on Switzerland of 39% that the US announced yesterday is likely be negotiated down in future and, importantly, pharmaceutical goods still appear to be exempt for the time being. However, if this tariff were to remain in place it would knock around 0.6% off Swiss GDP and significantly more if the exemption on pharmaceutical goods is removed.
Subscriber content
Read this in full, free
Start a free trial and use one of your 10 free starter credits to unlock this piece.